Total Funding
41
58
Total FundingPost-IPO Equity raised
Growth Score 41 in past quarter
-24 pts
Heat Score 58 in past quarter
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
48919
Zomedica is a veterinary pharmaceutical company.
Shameze Rampertab: Interim CEO & CFOPast Role: Profound Medical, CFO and Secretary
Jerry Solensky: Chairman & Chief Executive OfficerPast Role: Indymac Bank, Senior Vice President
About the Company
Zomedica Pharmaceuticals is a veterinary pharmaceutical company targeting health and wellness solutions for companion animals through a ground-breaking approach that focuses on the unmet needs of clinical veterinarians. It is building a diversified portfolio of products comprised of the discovery, development, and commercialization of innovative
drugs alongside novel drug delivery systems, devices, and diagnostics.
Women Founded
